RecruitingNCT04916652

A First-ever Research Collaboration to Characterize MRI Measured Neural Flexibility Development in Chinese Toddlers


Sponsor

Société des Produits Nestlé (SPN)

Enrollment

60 participants

Start Date

Apr 6, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The overall objective is to characterize the developmental characteristics of MRI measured neural flexibility, as an index of cognitive flexibility, in Chinese toddlers (32 to 42 months old).


Eligibility

Min Age: 32 MonthsMax Age: 34 Months

Inclusion Criteria10

  • Written informed consent has been obtained from the parent/legally acceptable representative.
  • Full-term birth (≥ 37 weeks and ≥ 2.5kg)
  • Typically developing Children aged between 32-34 months (2 years 8 months to 2 years10 month of age) at enrolment
  • Neurotypical development as assessed by interview
  • No major risk factors for learning, neurologic, or psychiatric disorder as assessed by interview \[defined as a diagnosed learning neurologic or psychiatric disorder in a first degree relative (e.g. parents, siblings)\].
  • Dietary requirement detailed below:
  • S-26 GOLD or ULTIMA GUM--fed group:
  • I. Daily consumption of S-26 GOLD or ULTIMA GUM for the last 60 days (2 months) II. Desire of the parent to continue feeding GUM during the course of the study
  • Cow's milk-fed group:
  • I. Daily consumption of cow's milk or for the last 60 days (2 months) II. Desire of the parent to continue feeding cow's milk during the course of the study

Exclusion Criteria8

  • Delayed birth ( \> 41 weeks gestation) as reported in medical record
  • Birth Weight \< 2500 g or small for gestational age (birth weight below the 10th percentile) or large for gestational age (birth weight above the 90th percentile) as reported in medical record
  • History of neurological (e.g., head injury, epilepsy), psychiatric or developmental disorder in the toddler as assessed by interview
  • History of diagnosed neurological (e.g., head injury, epilepsy), psychiatric or developmental disorder in parents or siblings, as assessed by interview
  • In utero exposure to alcohol abuse or illicit substances as defined as diagnosis of current substance use disorder in the biological mother and guidelines set by the American College of Obstetricians and Gynecologists and the Royal College of Physicians
  • Multiple birth as reported in medical record
  • Complicated pregnancy (e.g., preeclampsia, gestational diabetes) as assessed by medical interview/ medical record
  • Abnormal screening laboratory values and studies considered to be clinically significant in the opinion of the Investigator (e.g., metabolic disease screening, neonatal bilirubin)

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

RADIATIONMRI

MRI is a safe, non-invasive, cutting edge imaging technology widely used to study the human brain both internationally (NIH connectome project) and in China (China Brain Project). The Baby Connectome Project (BCP) led by NIH scientists has begun data collection on the structural and functional brain development among American infants (Howell, Styner et al. 2019).


Locations(1)

Shanghai Children's Medical Center

Shanghai, Shanghai Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04916652


Related Trials